PRPF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.261600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.020400E-01
Normal-vs-Stage2
6.435600E-01
Normal-vs-Stage3
2.138000E-01
Normal-vs-Stage4
7.373000E-01
Stage1-vs-Stage2
7.723600E-01
Stage1-vs-Stage3
2.691700E-02
Stage1-vs-Stage4
9.135800E-01
Stage2-vs-Stage3
6.481800E-02
Stage2-vs-Stage4
7.033400E-01
Stage3-vs-Stage4
2.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.180000E-01
Normal-vs-AfricanAmerican
8.038400E-01
Normal-vs-Asian
7.047800E-01
Caucasian-vs-AfricanAmerican
2.395400E-01
Caucasian-vs-Asian
5.607200E-01
AfricanAmerican-vs-Asian
5.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.334000E-01
Normal-vs-Female
6.192200E-01
Male-vs-Female
8.197200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.037600E-01
Normal-vs-Age(41-60Yrs)
7.504400E-01
Normal-vs-Age(61-80Yrs)
5.739600E-01
Normal-vs-Age(81-100Yrs)
5.594200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.024800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.745000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.442200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.911600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.896500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.232200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.267400E-01
Normal-vs-Daily Drinker
5.020800E-01
Normal-vs-Weekly Drinker
6.928000E-01
Normal-vs-Occasional Drinker
7.239000E-01
Normal-vs-Social Drinker
7.211800E-01
Non Drinker-vs-Daily Drinker
2.442800E-01
Non Drinker-vs-Weekly Drinker
6.616200E-01
Non Drinker-vs-Occasional Drinker
4.946400E-01
Non Drinker-vs-Social Drinker
2.792800E-01
Daily Drinker-vs-Weekly Drinker
1.299160E-01
Daily Drinker-vs-Occasional Drinker
7.579600E-02
Daily Drinker-vs-Social Drinker
8.200300E-02
Weekly Drinker-vs-Occasional Drinker
8.464000E-01
Weekly Drinker-vs-Social Drinker
5.575400E-01
Occasional Drinker-vs-Social Drinker
6.452000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.484200E-01
Normal-vs-Grade 2
6.707200E-01
Normal-vs-Grade 3
1.775220E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.676600E-01
Grade 1-vs-Grade 3
9.021900E-02
Grade 1-vs-Grade 4
4.484200E-01
Grade 2-vs-Grade 3
1.259610E-01
Grade 2-vs-Grade 4
6.707200E-01
Grade 3-vs-Grade 4
1.775220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.035000E-01
Normal-vs-NonDiabetic
6.855800E-01
Diabetic-vs-NonDiabetic
1.446430E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.625200E-01
Normal-vs-NoPancreatitis
5.871000E-01
Pancreatitis-vs-NoPancreatitis
9.230100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.892400E-01
Normal-vs-N1
6.073800E-01
N0-vs-N1
2.765000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.593000E-01
Normal-vs-TP53-NonMutant
6.790200E-01
TP53-Mutant-vs-TP53-NonMutant
4.138000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
